- Home
- VERO vs NITO Comparison
VERO vs NITO Comparison
Compare VERO & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- NITO
- Stock Information
- Founded
- VERO N/A
- NITO 2009
- Country
- VERO Canada
- NITO Israel
- Employees
- VERO N/A
- NITO N/A
- Industry
- VERO Medical/Dental Instruments
- NITO
- Sector
- VERO Health Care
- NITO
- Exchange
- VERO Nasdaq
- NITO NYSE
- Market Cap
- VERO 2.4M
- NITO N/A
- IPO Year
- VERO N/A
- NITO N/A
- Fundamental
- Price
- VERO $2.36
- NITO $0.21
- Analyst Decision
- VERO
- NITO
- Analyst Count
- VERO 0
- NITO 0
- Target Price
- VERO N/A
- NITO N/A
- AVG Volume (30 Days)
- VERO 78.4K
- NITO 480.4K
- Earning Date
- VERO 03-31-2025
- NITO 05-14-2025
- Dividend Yield
- VERO N/A
- NITO N/A
- EPS Growth
- VERO N/A
- NITO N/A
- EPS
- VERO N/A
- NITO N/A
- Revenue
- VERO $64,833,000.00
- NITO $210,000.00
- Revenue This Year
- VERO N/A
- NITO N/A
- Revenue Next Year
- VERO $4.95
- NITO N/A
- P/E Ratio
- VERO N/A
- NITO N/A
- Revenue Growth
- VERO N/A
- NITO N/A
- 52 Week Low
- VERO $2.16
- NITO $0.16
- 52 Week High
- VERO $17.49
- NITO $3.49
- Technical
- Relative Strength Index (RSI)
- VERO 40.66
- NITO 27.48
- Support Level
- VERO $2.20
- NITO $0.21
- Resistance Level
- VERO $4.03
- NITO $0.28
- Average True Range (ATR)
- VERO 0.47
- NITO 0.02
- MACD
- VERO -0.05
- NITO 0.01
- Stochastic Oscillator
- VERO 10.70
- NITO 16.71
Stock Price Comparison Chart: VERO vs NITO
■ VERO
■ NITO
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
Share on Social Networks:
0